Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe new screenshot shows an added 'Revision: v3.3.3' line and removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer, reflecting a minor site revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe government funding status banner was removed from the page; the study history table and links remain unchanged.SummaryDifference0.6%

- Check60 days agoChange DetectedThe new screenshot shows a minor visual refresh of the Record History page (slightly different header/footer styling) with no additions or removals in the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check88 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference11%

- Check95 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.